HK Stock MarketDetailed Quotes

00883 CNOOC

Watchlist
  • 21.550
  • +0.350+1.65%
Not Open Aug 30 16:08 CST
1.02TMarket Cap6.69P/E (TTM)

CNOOC Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Turnover
18.07%226.77B
14.08%111.47B
-1.33%416.61B
-1.39%306.82B
-5.09%192.06B
7.50%97.71B
71.56%422.23B
--311.15B
83.57%202.36B
--90.9B
Operating income
18.07%226.77B
14.08%111.47B
-1.33%416.61B
-1.39%306.82B
-5.09%192.06B
7.50%97.71B
71.56%422.23B
311.15B
83.57%202.36B
90.9B
Operating expenses
-4.61%-51.91B
-9.15%-154.65B
-31.18%-49.63B
-141.69B
-37.83B
Gross profit
23.85%59.55B
-10.20%152.17B
-9.39%48.08B
169.46B
53.07B
Selling expenses
-4.63%-5.22B
-1.14%-884M
-4.62%-10.95B
-5.60%-2.62B
-13.98%-4.99B
-13.51%-874M
-16.82%-10.47B
---2.48B
-13.07%-4.38B
---770M
Administrative expenses
----
-22.51%-1.62B
----
-16.41%-4.78B
----
-7.12%-1.32B
----
---4.1B
----
---1.24B
Research and development expenses
----
4.27%-336M
----
-46.43%-1.19B
----
-56.00%-351M
----
---812M
----
---225M
Profit from asset sales
----
50.00%3M
----
-114.29%-2M
----
-33.33%2M
----
--14M
----
--3M
Depreciation and amortization
-11.31%-37.56B
----
-9.70%-68.95B
----
-14.34%-33.74B
----
-9.81%-62.85B
----
-2.04%-29.51B
----
Revaluation surplus
----
-89.87%56M
----
222.00%483M
----
1,070.18%553M
----
--150M
----
---57M
-Changes in the fair value of other assets
----
-89.87%56M
----
222.00%483M
----
1,070.18%553M
----
--150M
----
---57M
Impairment and provision
88.67%-34M
-2,400.00%-25M
-440.09%-3.6B
-184.82%-319M
-191.26%-300M
66.67%-1M
91.63%-666M
---112M
-80.70%-103M
---3M
-Other impairment is provision
88.67%-34M
-2,400.00%-25M
-440.09%-3.6B
-184.82%-319M
-191.26%-300M
66.67%-1M
91.63%-666M
---112M
-80.70%-103M
---3M
Special items of operating profit
-12.69%-68.06B
-36.79%615M
-3.58%-141.01B
1.35%3.99B
2.72%-60.39B
666.14%973M
-110.07%-136.14B
--3.94B
-129.43%-62.08B
--127M
Operating profit
25.24%105.54B
20.76%52.29B
-13.22%167.77B
-11.90%133.92B
-13.18%84.27B
-7.16%43.3B
101.42%193.33B
152B
113.57%97.06B
46.64B
Financing income
12.91%2.6B
----
61.24%4.81B
----
106.28%2.3B
----
122.22%2.98B
----
105.72%1.12B
----
Financing cost
-18.86%-3.33B
532.65%310M
11.17%-5.35B
65.75%-744M
9.82%-2.8B
107.17%49M
-0.13%-6.03B
---2.17B
-9.41%-3.11B
---683M
Share of profits of associates
-4.96%402M
----
28.21%850M
----
40.07%423M
----
8.51%663M
----
-17.26%302M
----
Share of profit from joint venture company
-62.26%160M
----
-13.38%1.08B
----
-24.69%424M
----
570.94%1.25B
----
441.35%563M
----
Special items of earning before tax
-79.87%403M
23.08%-60M
48.12%3.82B
-61.19%-216M
2.19%2B
-178.57%-78M
-38.16%2.58B
---134M
45.00%1.96B
---28M
Earning before tax
22.11%105.78B
21.42%52.54B
-11.19%172.97B
-11.18%132.96B
-11.52%86.62B
-5.79%43.27B
103.26%194.77B
149.69B
117.68%97.9B
45.93B
Tax
-13.80%-26.03B
-14.79%-12.81B
7.93%-48.88B
13.78%-35.3B
12.07%-22.87B
4.01%-11.16B
-108.09%-53.09B
---40.94B
-123.36%-26.02B
---11.63B
After-tax profit from continuing operations
25.09%79.75B
23.72%39.73B
-12.41%124.09B
-10.21%97.66B
-11.32%63.75B
-6.39%32.11B
101.51%141.68B
108.76B
115.70%71.88B
34.3B
Earning after tax
25.09%79.75B
23.72%39.73B
-12.41%124.09B
-10.21%97.66B
-11.32%63.75B
-6.39%32.11B
101.51%141.68B
108.76B
115.70%71.88B
34.3B
Minority profit
207.69%14M
275.00%7M
1,173.91%247M
240.00%14M
-225.00%-13M
-300.00%-4M
-76.92%-23M
---10M
-33.33%-4M
---1M
Profit attributable to shareholders
25.05%79.73B
23.69%39.72B
-12.60%123.84B
-10.23%97.65B
-11.30%63.76B
-6.38%32.11B
101.51%141.7B
108.77B
115.69%71.89B
34.3B
Basic earnings per share
25.37%1.68
23.53%0.84
-14.19%2.6
-12.39%2.05
-14.65%1.34
-11.69%0.68
92.99%3.03
2.34
109.33%1.57
0.77
Diluted earnings per share
25.37%1.68
23.53%0.84
-14.19%2.6
-12.39%2.05
-14.65%1.34
-11.69%0.68
92.99%3.03
2.34
109.33%1.57
0.77
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
Ernst & Young (Special General Partnership), Ernst & Young
--
--
--
Ernst & Young (Special General Partnership), Ernst & Young
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Turnover 18.07%226.77B14.08%111.47B-1.33%416.61B-1.39%306.82B-5.09%192.06B7.50%97.71B71.56%422.23B--311.15B83.57%202.36B--90.9B
Operating income 18.07%226.77B14.08%111.47B-1.33%416.61B-1.39%306.82B-5.09%192.06B7.50%97.71B71.56%422.23B311.15B83.57%202.36B90.9B
Operating expenses -4.61%-51.91B-9.15%-154.65B-31.18%-49.63B-141.69B-37.83B
Gross profit 23.85%59.55B-10.20%152.17B-9.39%48.08B169.46B53.07B
Selling expenses -4.63%-5.22B-1.14%-884M-4.62%-10.95B-5.60%-2.62B-13.98%-4.99B-13.51%-874M-16.82%-10.47B---2.48B-13.07%-4.38B---770M
Administrative expenses -----22.51%-1.62B-----16.41%-4.78B-----7.12%-1.32B-------4.1B-------1.24B
Research and development expenses ----4.27%-336M-----46.43%-1.19B-----56.00%-351M-------812M-------225M
Profit from asset sales ----50.00%3M-----114.29%-2M-----33.33%2M------14M------3M
Depreciation and amortization -11.31%-37.56B-----9.70%-68.95B-----14.34%-33.74B-----9.81%-62.85B-----2.04%-29.51B----
Revaluation surplus -----89.87%56M----222.00%483M----1,070.18%553M------150M-------57M
-Changes in the fair value of other assets -----89.87%56M----222.00%483M----1,070.18%553M------150M-------57M
Impairment and provision 88.67%-34M-2,400.00%-25M-440.09%-3.6B-184.82%-319M-191.26%-300M66.67%-1M91.63%-666M---112M-80.70%-103M---3M
-Other impairment is provision 88.67%-34M-2,400.00%-25M-440.09%-3.6B-184.82%-319M-191.26%-300M66.67%-1M91.63%-666M---112M-80.70%-103M---3M
Special items of operating profit -12.69%-68.06B-36.79%615M-3.58%-141.01B1.35%3.99B2.72%-60.39B666.14%973M-110.07%-136.14B--3.94B-129.43%-62.08B--127M
Operating profit 25.24%105.54B20.76%52.29B-13.22%167.77B-11.90%133.92B-13.18%84.27B-7.16%43.3B101.42%193.33B152B113.57%97.06B46.64B
Financing income 12.91%2.6B----61.24%4.81B----106.28%2.3B----122.22%2.98B----105.72%1.12B----
Financing cost -18.86%-3.33B532.65%310M11.17%-5.35B65.75%-744M9.82%-2.8B107.17%49M-0.13%-6.03B---2.17B-9.41%-3.11B---683M
Share of profits of associates -4.96%402M----28.21%850M----40.07%423M----8.51%663M-----17.26%302M----
Share of profit from joint venture company -62.26%160M-----13.38%1.08B-----24.69%424M----570.94%1.25B----441.35%563M----
Special items of earning before tax -79.87%403M23.08%-60M48.12%3.82B-61.19%-216M2.19%2B-178.57%-78M-38.16%2.58B---134M45.00%1.96B---28M
Earning before tax 22.11%105.78B21.42%52.54B-11.19%172.97B-11.18%132.96B-11.52%86.62B-5.79%43.27B103.26%194.77B149.69B117.68%97.9B45.93B
Tax -13.80%-26.03B-14.79%-12.81B7.93%-48.88B13.78%-35.3B12.07%-22.87B4.01%-11.16B-108.09%-53.09B---40.94B-123.36%-26.02B---11.63B
After-tax profit from continuing operations 25.09%79.75B23.72%39.73B-12.41%124.09B-10.21%97.66B-11.32%63.75B-6.39%32.11B101.51%141.68B108.76B115.70%71.88B34.3B
Earning after tax 25.09%79.75B23.72%39.73B-12.41%124.09B-10.21%97.66B-11.32%63.75B-6.39%32.11B101.51%141.68B108.76B115.70%71.88B34.3B
Minority profit 207.69%14M275.00%7M1,173.91%247M240.00%14M-225.00%-13M-300.00%-4M-76.92%-23M---10M-33.33%-4M---1M
Profit attributable to shareholders 25.05%79.73B23.69%39.72B-12.60%123.84B-10.23%97.65B-11.30%63.76B-6.38%32.11B101.51%141.7B108.77B115.69%71.89B34.3B
Basic earnings per share 25.37%1.6823.53%0.84-14.19%2.6-12.39%2.05-14.65%1.34-11.69%0.6892.99%3.032.34109.33%1.570.77
Diluted earnings per share 25.37%1.6823.53%0.84-14.19%2.6-12.39%2.05-14.65%1.34-11.69%0.6892.99%3.032.34109.33%1.570.77
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----Ernst & Young (Special General Partnership), Ernst & Young------Ernst & Young (Special General Partnership), Ernst & Young------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg